To prepare students to make their own contributions to the rapidly expanding field of biomedical engineering (BME), the master’s program in BME provides a solid academic foundation and the opportunity to conduct research and development at the cutting edge of life science and engineering.
The BME environment at Ohio University includes faculty from four colleges who are working together to improve the human condition. The faculty utilizes expertise in engineering, biology, chemistry, mathematics, medicine, and physics to tackle some of the most difficult problems related to human health. Faculty projects include:
- Using fundamental physics and engineering in conjunction with cellular and molecular biology to further our understanding of autoimmune-inflammatory disease and to identify novel therapeutics
- Probing the means by which cancer spreads through the body
- Investigating the onset and progression of endocrine diseases, particularly those involved with growth disorders and diabetes, using animal models and proteomics
- Probing ion channels to gain a fundamental understanding of cell physiology
- Using combinatorial chemistry and RNA chemical biology to develop small molecule therapeutics including compounds that could be used to kill antibiotic-resistant bacteria
- Designing computer algorithms that allow scientists to track brain deterioration in Alzheimer’s patients
- Developing software packages that enable investigators to rapidly screen for undiscovered diagnostic and therapeutic molecular targets
- Creating artificial intelligence systems to aid in the care of diabetic patients
- Developing computer workstations that allow medical students to practice their skills in a virtual environment
- Using mechanical engineering analysis to increase understanding of bone damage and to guide the development of prosthetic devices
- Investigating the mechanisms of impaired acoustical processing and communication disorders and seeking to find therapies to alleviate these disabilities.
Several BME faculty are associated with Ohio University’s Edison Biotechnology Institute (EBI), which uses state-of-the-art cellular and molecular biology to convert basic knowledge into products for the diagnosis and treatment of disease. Ohio University and EBI were instrumental in the founding and growth of Diagnostic Hybrids Inc. (DHI), which is now a thriving biotechnology company based in Athens, Ohio.
BME faculty have received prestigious external grants for research. Over the past five years, grantors have included the National Science Foundation (including two CAREER Awards), National Institutes of Health (including RO1s and STTRs), American Heart Association, Whitaker Foundation, and Osteopathic Heritage Foundation. Also, more than $4 million has come from private industry and the state of Ohio for biotechnology development. Faculty routinely publish in high-profile journals including The Proceedings of the National Academy of Sciences, Journal of Biological Chemistry, Biotechnology and Bioengineering, and the Journal of Immunology.